by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersPharmathen International S.A.

All Warning Letters

Pharmathen International S.A.

Warning LetterOpen

44 Kifissias Ave. 15125 Marousi Attica GreeceFEI 3009961173Issued May 27, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3009961173.

Violations5

Issue DateMay 27, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Pharmathen International S.A.
Location: 44 Kifissias Ave. 15125 Marousi Attica Greece
FEI Number: 3009961173
Country: Greece
Issue Date: May 27, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Pharmathen International S.A. FDA Warning Letter, May 27, 2026